Evidence map›Paper›PMID 42298007›Full record

ArticleScientific reports2026

DRQuantum: a drug repurposing method by quantum walks on a multi-layered heterogeneous network.

Zengjing Chen, Xin Guo, Hao Jiang, Zhiping Liu, Ziqi Lu

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zengjing Chen *Shandong National Center for Applied Mathematics, Shandong University, Jinan, 250100, China.
Xin GuoShandong National Center for Applied Mathematics, Shandong University, Jinan, 250100, China.
Hao Jiang *Department of Mathematics, Shandong University, Jinan, 250100, China. 907960709@qq.com.
Zhiping LiuShandong National Center for Applied Mathematics, Shandong University, Jinan, 250100, China.
Ziqi LuZhongtai Securities Institute for Financial Studies, Shandong University, Jinan, 250100, China.

Funding

National Key R&D Program of China 2018YFA0703900National Natural Science Foundation of China 11901352
6 · The paper itself

Abstract

Traditional drug development poses significant financial and temporal costs, whereas drug repurposing emerges as a cost-effective and efficient alternative. As large-scale biological networks proliferate, computational drug repurposing has become feasible, yet accurately capturing intricate heterogeneous network structures remains a persistent challenge. To address this challenge, we introduced a novel approach, called DRQuantum: Drug Repurposing via Quantum walks. Unlike random walks, quantum walks dispense with independence and harness quantum entanglement to simultaneously explore multiple paths, enabling faster traversal of networks. Moreover, DRQuantum accounts for both the local and global network structures. In this study, we constructed a heterogeneous multi-layer network by integrating drug-drug, disease-disease and protein-protein interaction networks. We then employed quantum walks to learn low-dimensional feature representations of nodes in these heterogeneous networks, ultimately inferring candidate drugs for repurposing beyond their original indications. Consequently, we observed that DRQuantum outperforms traditional drug repurposing methods in terms of AUROC, AUPRC and accuracy. Additionally, case studies for several specific diseases further validate the practical utility of our proposed method.

Indexed as

Computational BiologyDrug RepositioningAlgorithmsHumansProtein Interaction MapsQuantum MechanicsQuantum TheoryDrug repurposingHeterogeneous networksNetwork embeddingQuantum walks

Identifiers

PMID42298007
PMCPMC13529718

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.